- in October 2021, Stryker set up an R&D lab in Australia (Queensland), which builds on the existing partnerships with researchers, hospitals, universities, and local governments, to drive the transformation of research into practical, commercially accessible precision medical device technology. This innovative R&D Lab will also associate with the company’s CMF instruments and endoscopy, medical, joint replacement, spine, & trauma, and extremities divisions to focus on research that drives technology platforms that can be used across facility lines over the upcoming years.
- in September 2020, The SpineJack implantable fracture reduction system developed by Stryker received the new technology add-on payment from the U.S. Centers for Medicare & Medicaid Services (CMS) as a component of the 2021 inpatient prospective payment system.
